Active substanceKetoprofenKetoprofen
Similar drugsTo uncover
  • Arketal Rompharm
    solution w / m in / in 
  • Arthrosilen
    suppositories rect. 
  • Arthrosilen
    gel externally 
  • Arthrosilen
    aerosol externally 
  • Arthrosilen
    solution w / m in / in 
  • Arthrosilen
    capsules inwards 
  • Artrum
    solution w / m in / in 
    BIOSINTEZ, PAO     Russia
  • Artrum
    suppositories rect. 
    BIOSINTEZ, PAO     Russia
  • Artrum
    pills inwards 
    BIOSINTEZ, PAO     Russia
  • Artrum
    gel externally 
    BIOSINTEZ, PAO     Russia
  • Bystrumgel®
    gel externally 
    AKRIKHIN HFK, JSC     Russia
  • Bystrumcaps
    capsules inwards 
  • VALUSAL®
    gel externally 
    GRINDEX, JSC     Latvia
  • Ketonal®
    gel externally 
    Sandoz d.     Slovenia
  • Ketonal
    solution w / m in / in 
    Lek dd     Slovenia
  • Ketonal
    pills inwards 
    Lek dd     Slovenia
  • Ketonal
    cream externally 
    Sandoz d.     Slovenia
  • Ketonal®
    suppositories rect. 
    Lek dd     Slovenia
  • Ketonal
    pills inwards 
    Lek dd     Slovenia
  • Ketonal®
    capsules inwards 
    Lek dd     Slovenia
  • Ketonal® DUO
    capsules inwards 
    Lek dd     Slovenia
  • Ketonal® UNO
    capsules inwards 
    Lek dd     Slovenia
  • Ketoprofen
    gel externally 
    VERTEKS, AO     Russia
  • Ketoprofen
    gel externally 
  • Ketoprofen
    gel externally 
    VetProm AD     Bulgaria
  • Ketoprofen
    solution w / m in / in 
  • Ketoprofen
    suppositories rect. 
    FARMPROJECT, CJSC     Russia
  • Ketoprofen
    gel externally 
  • Ketoprofen
    gel externally 
    VERTEKS, AO     Russia
  • Ketoprofen
    gel externally 
    ATOLL, LLC     Russia
  • Ketoprofen
    pills inwards 
    BIOKOM, CJSC     Russia
  • Ketoprofen
    gel externally 
  • Ketoprofen
    solution w / m in / in 
    VetProm AD     Bulgaria
  • Ketoprofen
    solution w / m in / in 
    HIMFARM, JSC     Kazakhstan
  • Ketoprofen
    solution w / m in / in 
    ATOLL, LLC     Russia
  • Ketoprofen
    solution w / m in / in 
    ELLARA, LTD.     Russia
  • Ketoprofen
    solution w / m in / in 
  • Ketoprofen
    pills inwards 
    VERTEKS, AO     Russia
  • Ketoprofen
    gel externally 
  • Ketoprofen Vramed
    gel externally 
    Sopharma, AO     Bulgaria
  • Ketoprofen MB
    pills inwards 
    BIOKOM, CJSC     Russia
  • Ketoprofen Organica
    capsules inwards 
    ORGANICS, JSC     Russia
  • Ketoprofen Organica
    pills inwards 
    ORGANICS, JSC     Russia
  • Ketoprofen Organica
    solution w / m in / in 
    ORGANICS, JSC     Russia
  • Ketoprofen-SOLOfarm
    solution w / m in / in 
    GROTEKS, LLC     Russia
  • Ketoprofen-ESCOM
    solution w / m in / in 
    ESKOM NPK, OAO     Russia
  • OCI
    suppositories rect. 
    Dompe SpA     Italy
  • OCI
    granules inwards 
    Dompe SpA     Italy
  • OCI
    solution locally 
    Dompe SpA     Italy
  • OCI
    suppositories rect. 
  • Pentalgin® extra-gel
    gel externally 
    OTISIFARM, OJSC     Russia
  • Spazgel®
    gel externally 
  • Fastum®
    gel externally 
  • Fibrofid®
    gel externally 
  • Flamax®
    capsules inwards 
  • Flamax®
    solution w / m in / in 
  • Flamax forte®
    pills inwards 
  • Fleksen
    capsules inwards 
    Italfarmaco SpA     Italy
  • Fleksen
    suppositories rect. 
    Italfarmaco SpA     Italy
  • Fleksen
    gel externally 
    Italfarmaco SpA     Italy
  • Fleksen
    lyophilizate w / m 
    Italfarmaco SpA     Italy
  • Dosage form: & nbspcapsules
    Composition:

    1 capsule contains:

    active substance: ketoprofen 50 mg;

    Excipients: giprolose (hydroxypropylcellulose, klucel LF) 1.2 mg, mannitol (mannitol) 10.5 g, croscarmellose sodium (impellose) 2.7 mg, cellulose microcrystalline 24.2 mg, silicon dioxide colloid (aerosil) 0.5 mg, magnesium stearate 0.9 mg;

    composition of the capsule shell of gelatin: sunset yellow (E 110) or yellow sunset 2.00%, titanium dioxide 2.00%, gelatin to 100%.

    Description:

    Contents of the capsules: white granules with a yellowish or creamy hue of color.

    Capsules of orange color № 2.

    Pharmacotherapeutic group:Non-steroidal anti-inflammatory drug (NSAID)
    ATX: & nbsp

    M.02.A.A.10   Ketoprofen

    Pharmacodynamics:

    Non-steroidal anti-inflammatory drug, a derivative of propionic acid. Has anti-inflammatory, analgesic and antipyretic effects associated with the suppression of cyclooxygenase 1 and cyclooxygenase 2, regulating the synthesis Pg. By acting on the cyclooxygenase and lipoxygenase unit of arachidonic acid metabolism, it inhibits the synthesis of prostaglandins, leukotrienes and thromboxanes.It has central and peripheral analgesic action, powerful anti-bradykinin activity, stabilizes lysosomal membranes, causes significant inhibition of neutrophil activity in patients with rheumatoid arthritis. Does not have a catabolic effect on articular cartilage. The anti-inflammatory effect comes to the end of 1 week of admission.

    Pharmacokinetics:

    Suction. Absorption - fast, bioavailability - more than 90%. Ketoprofen quickly and fairly fully absorbed from the gastrointestinal tract.

    Half-life at ingestion 1-2 hours.

    Distribution. Up to 99% of adsorbed ketoprofen binds to plasma proteins, mainly e albumin. The maximum concentration of the drug in the plasma is achieved quickly because of the low volume of distribution (concentration 0.1-0.2 l / kg). The equilibrium concentration of ketoprofen is reached 24 hours after the start of its regular intake.

    Ketoprofen penetrates well into the synovial fluid and connective tissues. In a significant amount does not penetrate the blood-brain barrier (BBB). Although the concentration of ketoprofen in the synovial fluid is somewhat lower than in plasma,they are more stable (lasting up to 30 hours), as a result of which the pain syndrome and joint stiffness for a long time decrease.

    Metabolism, excretion. Ketoprofen is mainly metabolized in the liver, where it undergoes glucuronidation with the formation of esters with glucuronic acid, excreted by the kidneys (60-80%) for 24 hours. The excretion with caloric masses is less than 1%. The half-life of ketoprofen ranges from 1.6 to 1.9 hours. It does not possess cumulative properties, due to rapid and fairly complete excretion.

    Indications:

    Inflammatory and degenerative diseases of the musculoskeletal system: rheumatoid, psoriatic arthritis, Bechterew's disease (ankylosing spondylitis), gouty arthritis (in case of acute gout attacks quick-acting dosage forms are preferred), osteoarthritis.

    Pain syndrome: myalgia, ossalgia, neuralgia, tendonitis, arthralgia, bursitis, sciatica, adnexitis, otitis, headache and toothache, with oncological diseases, post-traumatic and postoperative pain syndrome accompanied by inflammation.

    Algodismenorea (as an analgesic agent).

    It is intended for symptomatic therapy, reducing pain and inflammation at the time of use, the progression of the disease is not affected.

    Contraindications:Hypersensitivity to the active ingredient and other components of the drug, as well as to other non-steroidal anti-inflammatory drugs. Complete or incomplete combination of bronchial asthma, recurrent nasal polyposis and paranasal sinuses and intolerance to acetylsalicylic acid or other NSAIDs (including in history); erosive and ulcerative lesions of the gastrointestinal tract and duodenum, active gastrointestinal bleeding: cerebrovascular or other bleeding; inflammatory bowel disease (ulcerative colitis, Crohn's disease) (stage of exacerbation); hemophilia and other disorders of blood clotting; uncompensated heart failure, period after aortocoronary shunting; severe hepatic insufficiency or active liver disease: severe renal failure (creatinine clearance less than 30 ml / min), progressive kidney disease, confirmed hyperkalemia; children's age (up to 15 years); pregnancy III trimester, the period of breastfeeding.
    The drug is not used for anesthesia before and during surgery due to high risk of bleeding, as well as for the treatment of chronic pain.

    Carefully:

    Anemia, bronchial asthma, alcoholism, tobacco smoking, alcoholic liver cirrhosis, hyperbilirubinemia, hepatic insufficiency, chronic renal failure (creatinine clearance 30-60 ml / min), ulcerative lesions of the gastrointestinal tract in the anamnesis, the presence of infection Helicobacter pylori, long-term use of non-steroidal anti-inflammatory drugs, diabetes mellitus, dehydration, sepsis, chronic heart failure, edema, arterial hypertension, blood diseases (including leukopenia), stomatitis, coronary heart disease, cerebrovascular diseases, dyslipidemia / hyperipidemia, peripheral arterial diseases, severe somatic diseases, simultaneous administration of oral glucocorticosteroids (including prednisolone), anticoagulants (including warfarin), antiplatelet agents (at t.ch. clopidogrel), selective serotonin reuptake inhibitors (incl.citalopram, fluoxetine, paroxetine, sertraline), advanced age, pregnancy (I and II trimester).

    Pregnancy and lactation:

    Contraindicated in pregnancy in III trimester (especially after 36 weeks) because of the possible effect on the tone of the uterus.

    Possible use with caution in pregnancy in the I and II trimester, if the expected effect of therapy exceeds the potential risk to the fetus.

    Women planning a pregnancy should refrain from the use of ketoprofen, tk. on the background of its administration, the probability of implantation of the ovule may decrease.

    Like other substances that are extracted into breast milk, it is not recommended to use ketoprofen nursing mothers.

    Dosing and Administration:

    Inside, during meals or immediately after meals, without chewing, with sufficient

    amount of water. Adults and adolescents (15-18 beds) are prescribed 4 capsules per day, which can be divided into 3 doses (and depending on the severity of the pain syndrome), but not more than 2 capsules once.

    The maximum daily dose of the drug should not exceed 200 mg.

    Side effects:

    The undesirable phenomena presented below are listed depending on the anatomical and physiological classification and frequency of occurrence.

    The incidence of side effects is defined as follows: very often -> 1/10 assignments (> 10%), often - 1 / 10-1 / 100 assignments (> 1% and <10%), infrequently - 1/100 to 1 / 1000 assignments (> 0.1% and <1%), rare - 1 / 1000-1 / 10000 assignments (> 0.01% and <0.1%), very rare <1/10000 assignments (<0.01 %, including single messages).

    From the digestive system: often - NSAID-gastropathy, abdominal pain, dyspepsia (nausea, vomiting, heartburn, flatulence, decreased appetite, diarrhea), infrequently - stomatitis, a violation of liver function; rarely - erosive and ulcerative lesions; very rarely - bleeding and perforation of the gastrointestinal tract, a change in taste.

    From the nervous system: often - headache, dizziness, insomnia, agitation, nervousness, drowsiness, depression, asthenia, rarely - confusion or loss of consciousness, forgetfulness, memory impairment, migraine, peripheral neuropathy.

    From the sense organs: rarely - noise or ringing in the ears, blurred vision, conjunctivitis, dry eye mucosa, eye pain, conjunctival hyperemia, hearing loss, dizziness, vertigo.

    From the side of the cardiovascular system: rarely - swelling, increased blood pressure, rarely - tachycardia.

    From the respiratory system: infrequently - hemoptysis, dyspnea, pharyngitis, rhinitis, bronchospasm, laryngeal edema (signs of anaphylactic reaction); rarely - asthma attacks.

    On the part of the organs of hematopoiesis: rarely - agranulocytosis, anemia, hemolytic anemia, thrombocytopenia, leukopenia. High doses of ketoprofen can inhibit platelet aggregation, thus prolonging the bleeding time, and cause nasal bleeding and hematoma formation.

    From the urinary system: infrequent - edematous syndrome, rarely - cystitis, urethritis, renal dysfunction, interstitial nephritis, nephrotic syndrome, very rarely - hematuria.

    From the immune system: infrequently, the reactivity of the respiratory system, including bronchial asthma, exacerbation, bronchospasm, or dyspnea (especially in patients with hypersensitivity to acetylsalicylic acid and other non-steroidal anti-inflammatory drugs); very rarely - angioedema and anaphylaxis.

    Allergic reactions: often - skin rash (including erythematous urticaria), itching of the skin, infrequently - rhinitis, rarely exfoliative dermatitis.

    Other: infrequent - increased sweating, rarely - epistaxis, myalgia, muscle twitching, shortness of breath, thirst, photosensitivity, with prolonged use in large doses - vaginal bleeding.

    Overdose:

    Cases of drug overdose are not described. There is no specific antidote. Treatment symptomatic.

    Interaction:

    Pharmaceutically incompatible with tramadol.

    Reduces the effectiveness of uricosuric, hypotensive drugs and diuretics, enhances the effect of anticoagulants, antiaggregants, fibrinolytics, ethanol, side effects of glucocorticosteroids and mineralocorticosteroids, estrogens.

    Joint use with salicylates and other NSAIDs, corticotropin can lead to the formation of ulcers and the development of gastrointestinal bleeding, to an increased risk of developing renal dysfunction.

    Simultaneous administration with oral anticoagulants, heparin, thrombolytics, antiplatelet agents, cefoperazone, cefamandole and cefotetan increase the risk of bleeding.

    Simultaneous application with potassium salts, potassium-sparing diuretics, angiotensin-converting enzyme (ACE) inhibitors,low-molecular heparins, tacrolimus and trimethoprim increases the risk of hyperkalemia and the development of renal dysfunction.

    Increases the concentration in the blood plasma of cardiac glycosides, blockers of "slow" calcium channels, verapamil, nifedepine, lithium preparations, cyclosporine, methotrexate and digoxin.

    Simultaneous use with probenecid significantly reduces the clearance of ketoprofen in blood plasma.

    Ketoprofen may reduce the effectiveness of mifepristone. The administration of ketoprofen should be started no earlier than 8-12 days after the withdrawal of mifepristone.

    Ketoprofen increases the hypoglycemic effect of insulin and oral hypoglycemic drugs (dose recalculation is necessary).

    Inductors of microsomal oxidation in the liver (phenytoin, barbiturates, rifampicin, phenylbutazone, tricyclic antidepressants) increase the production of hydroxylated active metabolites.

    With simultaneous use with pentoksifillinom increases anticoagulant effect and increases the risk of hemorrhagic complications.

    Co-administration with sodium valproate causes disruption of platelet aggregation.

    Antacids and colestramine reduce the absorption of ketoprofen.

    Myelotoxic drugs increase the manifestation of ketoprofen hematotoxicity.

    Special instructions:

    During treatment, it is necessary to monitor the picture of peripheral blood and the functional state of the liver and kidneys. If it is necessary to determine 17-ketosteroids, the drug should be discontinued 48 hours before the test.

    Reception of ketoprofen can mask signs of an infectious disease.

    If the kidney and liver function is impaired, a dose reduction and careful monitoring is necessary.

    Effect on the ability to drive transp. cf. and fur:

    During the treatment period, care must be taken when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

    Form release / dosage:

    Capsules 50 mg.

    Packaging:

    10 capsules in a contour cell box made of polyvinylchloride film and aluminum foil.

    For 20, 30 or 50 capsules in a can of lightproof glass.

    2, 3, 5 contour squares or each bank along with instructions for use in a pack of cardboard.

    Storage conditions:

    Store in a dark place at a temperature of no higher than 25 0 FROM.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use the product after the expiry date printed on the package.

    Terms of leave from pharmacies:On prescription
    Registration number:LP-002970
    Date of registration:23.04.2015 / 17.03.2017
    Expiration Date:23.04.2020
    The owner of the registration certificate:ORGANICS, JSC ORGANICS, JSC Russia
    Manufacturer: & nbsp
    Information update date: & nbsp06.01.2018
    Illustrated instructions
      Instructions
      Up